Combination Treatment With The Anti-Igf1r Antibody Mk-0646 And The Mtor Inhibitor Deforolimus Leads To More Effective Pi3k Pathway Targeting And Anti-Tumor Activity
CANCER RESEARCH（2009）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined